Effects of Bolus Administration of ORG-9426 in Children during Nitrous Oxide–Halothane Anesthesia

    loading  Checking for direct PDF access through Ovid


ORG-9426 is a new steroidal nondepolarizing neuromuscular blocking drug. We determined the dose–response relationship of ORG-9426 in 62 children (aged 1–5 yr) during nitrous oxide–halothane anesthesia by means of log-probit transformation and leastsquares linear regression of the initial dose and response. Twelve additional patients received a bolus of 600 μg/kg (2 X the dose estimated to produce 95% depression of neuromuscular function [ED95]) of ORG-9426. Neuromuscular blockade was monitored by recording the electromyographic activity of the adductor pollicis muscle resulting from supramaximal stimulation of the ulnar nerve at 2 Hz for 2 s at 10-s intervals. To determine the dose–response relationship, patients randomly received initial bolus doses of 120 (n = 15), 160 (n = 16), 200 (n = 16), or 240 (n = 15) μg/kg ORG-9426. The resulting dose estimated to produce 50% depression of neuromuscular function (ED50) and ED95 were 179 and 303 μg/kg, respectively. Time from administration of 600 μg/kg to onset of 90% and 100% neuromuscular block was 0.8 ± 0.1 (0.5–1.3) and 1.3 ± 0.2 (0.7–2.8) min. The time to recovery of neuromuscular transmission to 25% (T25) was 26.7 ± 1.9 (17.2–39.0) min. The recovery index (T25–75) was 11.0 ± 1.6 (6.0–22.8) min, and the time to complete recovery of the magnitude of the fourth response to a train-of-four stimuli divided by the magnitude of the first response (T4/T1) ≥ 0.75 was 41.9 ± 3.2 (26.5–57.7) min. The heart rate transiently increased from 90 ± 4 (68–108) to 106 ± 4 (76–122) beats/min (P < 0.01) within 1 min after ORG-9426 (2 X ED95) administration. The relatively rapid onset of action of a bolus of ORG-9426 that can produce paralysis and the minimal change in heart rate make this neuromuscular blocking drug useful in children in situations where rapid tracheal intubation is desired.

    loading  Loading Related Articles